UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
 
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported): July 12, 2012
 
MEDTOX SCIENTIFIC, INC.
  (Exact name of registrant as specified in its charter)
 
         
Delaware
 
1-11394
 
95-3863205
(State or other jurisdiction
of incorporation)
 
(Commission File Number)
 
(IRS Employer
Identification No.)
 
 
     
402 West County Road D, St. Paul, Minnesota
 
55112
(Address of principal executive offices)
 
(Zip Code)
 
Registrant’s telephone number, including area code: (651) 636-7466
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
¨
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
x
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
¨
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
¨
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 


Item 2.02.                      Results of Operations and Financial Condition

On July 12, 2012, MEDTOX Scientific, Inc. announced results for the second quarter ended June 30, 2012, as described in the press release attached as Exhibit 99.1.




 
- 2 -
 
 
Item 8.01.                      Other Events

On July 12, 2012, MEDTOX Scientific, Inc. issued a press release announcing the Company’s results for the quarter ended June 30, 2012. A copy of the press release is attached hereto as Exhibit 99.1 and incorporated herewith by reference.

 
- 3 - 
 

Item 9.01.                      Financial Statements and Exhibits .
 
 
(c)
Exhibits .
 
The following exhibit is filed as part of this report:
 
     
Exhibit No.
 
Description
99.1
 
MEDTOX Scientific, Inc. Press Release, dated July 12, 2012.
 



 
- 4 -
 


SIGNATURES


Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


MEDTOX Scientific, Inc.




Date:  July 12, 2012                                                                              By:         /s/ Richard J. Braun                           
Name:  Richard J. Braun
Title:    Chief Executive Officer


 
- 5 -
 

INDEX TO EXHIBITS

 
     
Exhibit No.
 
Description
99.1
 
MEDTOX Scientific, Inc. Press Release, dated July 12, 2012.
 

 

- 6 -
Medtox Scientific, Inc. (MM) (NASDAQ:MTOX)
Historical Stock Chart
From Oct 2024 to Nov 2024 Click Here for more Medtox Scientific, Inc. (MM) Charts.
Medtox Scientific, Inc. (MM) (NASDAQ:MTOX)
Historical Stock Chart
From Nov 2023 to Nov 2024 Click Here for more Medtox Scientific, Inc. (MM) Charts.